文献速递血栓与止血

遗传性出血性疾病患者静脉血栓栓塞症的患病率与危险因素:ATHN数据集研究

Prevalence and Risk Factors for Venous Thromboembolism in People With Inherited Bleeding Disorders: An ATHNdataset Study.
PubMed 文献 · Am J Hematol · 2025-09-27

该研究利用美国血栓与止血网络(ATHN)数据集,纳入49,151例遗传性出血性疾病患者,旨在明确静脉血栓栓塞症(VTE)的发生率和危险因素。共观察到388例新发VTE(0.8%;95% CI:0.7,0.9),凝血酶原缺乏症患者VTE发生率最高为19%,血友病A和B相对较低为0.4%。多变量分析显示,黑人种族(OR=1.90)、中心静脉导管(OR=2.76)和心脏合并症(OR=16.86)是VTE的危险因素。

要点

  • 遗传性出血性疾病患者VTE发生率为0.8%(95% CI:0.7,0.9),凝血酶原缺乏症最高达19%。
  • 血友病A和B患者VTE发生率为0.4%,合并抑制物者VTE发生率更高(p < 0.001)。
  • VTE复发率为4.9%(n=19/388),黑人种族、中心静脉导管和心脏合并症是危险因素。

核心结论

  • 遗传性出血性疾病患者并不能免于VTE风险,心脏合并症和中心静脉导管等个体因素可增加血栓风险。

研究设计与样本

  • 利用美国血栓与止血网络(ATHN)数据集进行的队列研究,纳入49,151例遗传性出血性疾病患者,其中388例发生VTE。

主要发现

  • 共观察到388例新发VTE(0.8%;95% CI:0.7,0.9),VTE诊断中位年龄27.5岁(IQR:15.3-48.2)。
  • 凝血酶原缺乏症患者VTE发生率为19%,血友病A和B患者为0.4%。
  • 血友病队列中,合并抑制物者VTE发生率更高(p < 0.001)。
  • VTE复发率为4.9%(n=19/388)。
  • 多变量分析显示,黑人种族(OR=1.90)、中心静脉导管(OR=2.76)和心脏合并症(OR=16.86)是VTE的危险因素。

关键数值与推荐

  • VTE总体发生率为0.8%(95% CI:0.7,0.9)。
  • 凝血酶原缺乏症VTE发生率为19%,血友病A和B为0.4%。
  • VTE复发率为4.9%(n=19/388)。
  • 黑人种族OR=1.90,中心静脉导管OR=2.76,心脏合并症OR=16.86。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

It is presumed that people with inherited bleeding disorders are protected against the risk of venous thromboembolism (VTE) but the supporting data regarding rates and risk factors for VTE in this population are lacking. The objectives of this study were to determine the VTE rates and risk factors in a cohort of individuals with inherited bleeding disorders. American Thrombosis and Hemostasis Network (ATHN) dataset was utilized for this study. The population of interest was individuals with an inherited bleeding disorder with a documented VTE. Data were collected regarding their bleeding disorder, demographics, type of VTE, and comorbidities. Data were summarized using standard descriptive analyses, and logistic regression analyses were used to identify risk factors. We identified a total of 49,151 individuals with inherited bleeding disorders in the ATHNdataset. A total of 388 new VTE (0.8%; 95% CI: 0.7, 0.9) were observed. Median age at VTE diagnosis was 27.5 years (IQR: 15.3-48.2). VTE rates were highest in prothrombin deficiency at 19% and relatively lower in hemophilia A and B at 0.4%. Within the hemophilia cohort, rates of VTE were higher in those with inhibitors (p < 0.001). The VTE recurrence rate was 4.9% (n = 19/388). On multivariable analysis, Black race (OR = 1.90), central venous line (CVL) (OR = 2.76), and cardiac comorbidity (OR = 16.86) were identified as risk factors for VTE. In summary, our results demonstrate that people with inherited bleeding disorders are not protected against VTE. Individual factors such as cardiac comorbidity and the presence of a CVL can increase the prothrombotic risk.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Agarwal S, Stanek JR, Hu J, et al. Prevalence and Risk Factors for Venous Thromboembolism in People With Inherited Bleeding Disorders: An ATHNdataset Study. Am J Hematol. 2025. PMID: 41014298. doi:10.1002/ajh.70092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。